Gastroenterology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Synova Healthcare, QuantRx Biomedical sign agreement to distribute hemorrhoid treatment
August 7th, 2006
Synova Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. (SNVH), has entered into an exclusive distribution agreement with QuantRx Biomedical Corporation, a medical technology company. Under the terms of the agreement, Synova has the exclusive right in the U.S. to market for a minimum of 5 years a product for the treatment and relief of hemorrhoids. According to the National Digestive Diseases Information Clearinghouse (NDDIC), half the U.S. population will experience hemorrhoids by the age of 50. Currently, there are more than 12.5 million people suffering from hemorrhoids, with an OTC market estimated at $300 million in the...
Source: Gastroenterology Week (2006-08-07)
|
